Evidence map›Paper›PMID 36380894›Full record

ArticleNeurology. Clinical practice2022

Online vs Face-to-Face Administration of Impulse Control Disorder Questionnaires in Parkinson Disease: Does Method Matter?

Bonnie M Scott, Robert S Eisinger, Revath Sankar, Jared F Benge, Robin C Hilsabeck, Michael S Okun, Aysegul Gunduz, Dawn Bowers

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurology. Clinical practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Bonnie M ScottDepartment of Clinical and Health Psychology (BMS, DB), University of Florida, Gainesville, FL; Department of Neurology (BMS, RS, JFB, RCH), Dell Medical School, University of Texas at Austin, Austin, TX; Department of Neuroscience (RSE, AG), Norman Fixel Institute of Neurological Diseases, University of Florida; Department of Neurology (MSO), Norman Fixel Institute of Neurological Diseases, University of Florida; and J. Crayton Pruitt Department of Biomedical Engineering (AG), University of Florida, Gainesville, FL.
Robert S EisingerDepartment of Clinical and Health Psychology (BMS, DB), University of Florida, Gainesville, FL; Department of Neurology (BMS, RS, JFB, RCH), Dell Medical School, University of Texas at Austin, Austin, TX; Department of Neuroscience (RSE, AG), Norman Fixel Institute of Neurological Diseases, University of Florida; Department of Neurology (MSO), Norman Fixel Institute of Neurological Diseases, University of Florida; and J. Crayton Pruitt Department of Biomedical Engineering (AG), University of Florida, Gainesville, FL.
Revath SankarDepartment of Clinical and Health Psychology (BMS, DB), University of Florida, Gainesville, FL; Department of Neurology (BMS, RS, JFB, RCH), Dell Medical School, University of Texas at Austin, Austin, TX; Department of Neuroscience (RSE, AG), Norman Fixel Institute of Neurological Diseases, University of Florida; Department of Neurology (MSO), Norman Fixel Institute of Neurological Diseases, University of Florida; and J. Crayton Pruitt Department of Biomedical Engineering (AG), University of Florida, Gainesville, FL.
Jared F BengeDepartment of Clinical and Health Psychology (BMS, DB), University of Florida, Gainesville, FL; Department of Neurology (BMS, RS, JFB, RCH), Dell Medical School, University of Texas at Austin, Austin, TX; Department of Neuroscience (RSE, AG), Norman Fixel Institute of Neurological Diseases, University of Florida; Department of Neurology (MSO), Norman Fixel Institute of Neurological Diseases, University of Florida; and J. Crayton Pruitt Department of Biomedical Engineering (AG), University of Florida, Gainesville, FL.
Robin C HilsabeckDepartment of Clinical and Health Psychology (BMS, DB), University of Florida, Gainesville, FL; Department of Neurology (BMS, RS, JFB, RCH), Dell Medical School, University of Texas at Austin, Austin, TX; Department of Neuroscience (RSE, AG), Norman Fixel Institute of Neurological Diseases, University of Florida; Department of Neurology (MSO), Norman Fixel Institute of Neurological Diseases, University of Florida; and J. Crayton Pruitt Department of Biomedical Engineering (AG), University of Florida, Gainesville, FL.
Michael S OkunDepartment of Clinical and Health Psychology (BMS, DB), University of Florida, Gainesville, FL; Department of Neurology (BMS, RS, JFB, RCH), Dell Medical School, University of Texas at Austin, Austin, TX; Department of Neuroscience (RSE, AG), Norman Fixel Institute of Neurological Diseases, University of Florida; Department of Neurology (MSO), Norman Fixel Institute of Neurological Diseases, University of Florida; and J. Crayton Pruitt Department of Biomedical Engineering (AG), University of Florida, Gainesville, FL.
Aysegul GunduzDepartment of Clinical and Health Psychology (BMS, DB), University of Florida, Gainesville, FL; Department of Neurology (BMS, RS, JFB, RCH), Dell Medical School, University of Texas at Austin, Austin, TX; Department of Neuroscience (RSE, AG), Norman Fixel Institute of Neurological Diseases, University of Florida; Department of Neurology (MSO), Norman Fixel Institute of Neurological Diseases, University of Florida; and J. Crayton Pruitt Department of Biomedical Engineering (AG), University of Florida, Gainesville, FL.
Dawn BowersDepartment of Clinical and Health Psychology (BMS, DB), University of Florida, Gainesville, FL; Department of Neurology (BMS, RS, JFB, RCH), Dell Medical School, University of Texas at Austin, Austin, TX; Department of Neuroscience (RSE, AG), Norman Fixel Institute of Neurological Diseases, University of Florida; Department of Neurology (MSO), Norman Fixel Institute of Neurological Diseases, University of Florida; and J. Crayton Pruitt Department of Biomedical Engineering (AG), University of Florida, Gainesville, FL.
University of Florida Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objective: Social desirability bias, the tendency to underreport undesirable behaviors, may be one reason patients with Parkinson disease (PD) underreport symptoms of impulse control disorders (ICDs). Methods: We compared rates of ICD endorsement on questionnaires administered face-to-face and online in 60 patients with mild-to-moderate idiopathic PD. Participants also completed a self-report measure of social desirability. Results: We found a significantly higher prevalence of any ICD based on online (56.7%) vs in-person (33.3%) administration. Significantly higher endorsement of items related to hypersexuality in men and compulsive eating and buying in women were found with online administration. Social desirability bias was positively correlated with ICD symptom endorsement across all items and subscales. Discussion: The results highlight the importance of social context/setting and the need for sensitivity and discretion when screening for ICD symptoms. Although a higher level of symptom endorsement does not necessarily imply a greater level of accuracy, more work is needed to determine which method of administration is most accurate for clinical and research practice.

Identifiers

PMID36380894
PMCPMC9647804
OpenAlexW4293843075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.